Skip to main content
SpringerLink
Log in

Drug Interactions with Phenytoin

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Drug interactions with phenytoin are a frequent occurrence, although their clinical relevance has often been overemphasised. Probably the most important of such interactions are those resulting in inhibition of phenytoin metabolism; due to the satumble nature of phenytoin biotransformation even minor degrees of inhibition can produce disproportionate changes in both steady-state serum concentration and the magnitude of pharmacological effect. Phenytoin has marked enzyme-inducing properties and can stimulate the metabolism of many concurrently administered drugs, thereby reducing their therapeutic efficacy. Clinically important examples of such interactions include a reduction of the anticoagulant effect of dicoumarol, a decrease in the prophylactic efficacy of the contraceptive pill and failure of response to various corticosteroid agents when administered therapeutically or diagnostically. Unless complicated by additional mechanisms, plasma protein binding interactions with phenytoin are seldom of clinical significance. However, they may alter considerably the relationship between serum drug concentration and clinical response, a possibility which needs to be taken into account when interpreting serum phenytoin levels in clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ahmad, S.: Renal insensitivity to frusemide caused by chronic anticonvulsant therapy. British Medical Journal 3: 657–659 (1974).

    PubMed  CAS  Google Scholar 

  • Aitio, M-L. and Vuorenmaa, T.: Enhanced metabolism and diminished efficacy of disopyramide by enzyme-induction. British Journal of Clinical Pharmacology 9: 149–152 (1980).

    PubMed  CAS  Google Scholar 

  • Ballek, R.E.; Reidenberg, M.M. and Orr, L.: Inhibition of diphenylhydantoin metabolism by chloramphenicol. Lancet 1: 150 (1973).

    PubMed  CAS  Google Scholar 

  • Baylis, E.M.; Crowley, J.M.; Preece, J.M.; Silvester, P.E. and Marks, V.: Influence of folic acid on blood-phenytoin levels. Lancet 1: 62–64(1971).

    PubMed  CAS  Google Scholar 

  • Bielmann, I.; Luac, T. and Gagnon, M.A.: Clonazepam: Its efficacy in association with phenytoin and phenobarbital in mental patients in generalized major motor seizures. International Journal of Clinical Pharmacology 16: 268–273 (1978).

    CAS  Google Scholar 

  • Bochner, F.; Hooper, W.D.; Tyrer, J.H. and Eadie, M.J.: Factors involved in an outbreak of phenytoin intoxication. Journal of the Neurological Sciences 16: 481–487 (1972).

    PubMed  CAS  Google Scholar 

  • Borgå, O.; Azarnoff, O.L.; Forshell, G.P. and Sjoqvist, F.: Plasma protein binding of tricyclic antidepressants in man. Biochemical Pharmacology 18: 2135–2143 (1969).

    PubMed  Google Scholar 

  • Boylan, J.J.; Owen, D.S. and Chin, J.B.: Phenytoin interference with dexamethasone. Journal of the American Medical Association 235: 803–804 (1976).

    PubMed  CAS  Google Scholar 

  • Braithwaite, R.A.; Flanagan, R.A. and Richens, A.: Steady-state plasma nortriptyline concentrations in epileptic patients. British Journal of Clinical Pharmacology 2: 469–471 (1975).

    PubMed  CAS  Google Scholar 

  • Brennan, R.W.; Dehejia, H.; Kutt, H.; Verebely, K. and McDowell, F.: Diphenylhydantoin intoxication attendant to show inactivation of isoniazid. Neurology 20: 687–693 (1970).

    PubMed  CAS  Google Scholar 

  • Chapron, D.J.; Kramer, P.A.; Mariano, S.L. and Hohnadel, D.C.: Effect of calcium and antacids on phenytoin bioavailability. Archives of Neurology 36: 436–438 (1979).

    PubMed  CAS  Google Scholar 

  • Choi, Y.; Thrasher, K.; Werk, E.E. Jr; Sholiton, L.J. and Olinger, C.: Effect of diphenylhydantoin on cortisol kinetics in humans. Journal of Pharmacology and Experimental Therapeutics 176: 27–34 (1971).

    PubMed  CAS  Google Scholar 

  • Coulam, C.B. and Annegers, J.F.: Do anticonvulsants reduce the efficacy of oral contraceptives? Epilepsia 20: 519–526 (1979).

    PubMed  CAS  Google Scholar 

  • Christensen, L.K. and Skovsted, L.: Inhibition of drug metabolism by chloramphenicol. Lancet 2: 1397–1399 (1969).

    PubMed  CAS  Google Scholar 

  • Cramer, J.A. and Mattson, R.H.: Valproic acid: in vitro plasma protein binding and interaction with phenytoin. Therapeutic Drug Monitoring 1: 105–116 (1979).

    PubMed  CAS  Google Scholar 

  • Dahlqvist, R.; Borgå, O.; Rane, A.; Walsh, Z. and Sjoqvist, F.: Decreased plasma protein binding of phenytoin in patients on valproic acid. British Journal of Clinical Pharmacology 8: 547–552 (1979).

    PubMed  CAS  Google Scholar 

  • Dam, M.; Jensen, A. and Christiansen, J.: Plasma level and effect of carbamazepine in grand mal and psychomotor epilepsy. Acta Neurologica Scandinavica 60 (Suppl.): 33–38 (1975).

    PubMed  CAS  Google Scholar 

  • Data, J.L.; Wilkinson, G.R. and Nies, A.S.: Interaction of quinidine with anticonvulsant drugs. New England Journal of Medicine 294: 699–702 (1976).

    PubMed  CAS  Google Scholar 

  • Davies, J.E.; Edmunson, W.F.; Carter, C.H. and Barquet, A.: Effects of anticonvulsant drugs on dicophane (DDT) residues in man. Lancet 2: 7–9 (1969).

    PubMed  CAS  Google Scholar 

  • Eichelbaum, M.; Köthe, K.W.; Hoffmann, F. and von Unruh, G.E.: Kinetics and metabolism of carbamazepine during combined antiepileptic therapy. Clinical Pharmacology and Therapeutics 26: 367–371 (1979).

    Google Scholar 

  • Fincham, R.W. and Schottelius, D.D.: Decreased phenytoin levels in antineoplastic therapy. Therapeutic Drug Monitoring 1: 277–283 (1979).

    PubMed  CAS  Google Scholar 

  • Fincham, R.W.; Schottelius, D.D. and Sahs, A.L.: The influence of diphenylhydantoin on primidone metabolism. Archives of Neurology 30: 259–262 (1974).

    PubMed  CAS  Google Scholar 

  • Fincham, R.W.: Wiley, D.E. and Schottelius, D.D.: Use of phenytoin serum levels in a case of status epilepticus. Neurology 26: 879–881 (1976).

    PubMed  CAS  Google Scholar 

  • Fine, A.; Henderson, I.S.; Morgan, D.R. and Tilstone, W.J.: Malabsorption of frusemide caused by phenytoin. British Medical Journal 2: 1061–1062 (1977).

    PubMed  CAS  Google Scholar 

  • Fraser, D.G.; Ludden, T.M.; Evens, R.P. and Sutherland, E.W.III: Displacement of phenytoin from plasma binding sites by salicylate. Clinical Pharmacology and Therapeutics 27: 165–169 (1980).

    PubMed  CAS  Google Scholar 

  • Friel, P.N.; Leal, K.W. and Wilensky, A.J.: Valproic acid-phenytoin interaction. Therapeutic Drug Monitoring 1: 243–248 (1979).

    PubMed  CAS  Google Scholar 

  • Furlanut, M.; Benetello, P.; Avogaro, A. and Dainese, R.: Effects of folic acid on phenytoin kinetics in healthy subjects. Clinical Pharmacology and Therapeutics 24: 294–297 (1978).

    PubMed  CAS  Google Scholar 

  • Gangji, D.; Schwade, J.G. and Strong, J.M.: Phenytoinmisonidazole: A possible metabolic interaction. Cancer Treatment Reports 64: 155–156 (1980).

    PubMed  CAS  Google Scholar 

  • Garrett, W.R.; Carter, B.L. and Pellock, J.M.: Bioavailability of phenytoin administered with antacids. Therapeutic Drug Monitoring 1: 435–437 (1979).

    Google Scholar 

  • Garrettson, L.K.; Perel, J.M. and Dayton, P.G.: Methylphenidate interaction with both anticonvulsants and ethyl-biscoumacetate. Journal of the American Medical Association 207: 2053–2056 (1969).

    PubMed  CAS  Google Scholar 

  • Ghose, K.: Effect of carbamazepine in polyuria associated with lithium therapy. Pharmakopsychiatrie Neuro-Psychopharmakologie 11: 241–245 (1978).

    CAS  Google Scholar 

  • Giacomini, K.; Giacomini, J. and Blaschke, T.: Heparin decreases plasma protein binding of drugs. Clinical Pharmacology and Therapeutics 27: 256 (1980).

    Google Scholar 

  • Hahn, T.J.: Bone complications of anticonvulsants. Drugs 12: 201–211 (1976).

    PubMed  CAS  Google Scholar 

  • Hansen, J.M.; Kristensen, M.; Skovsted, L. and Christensen, L.K.: Dicoumarol-induced diphenylhydantoin intoxication. Lancet 2: 265–266 (1966).

    PubMed  CAS  Google Scholar 

  • Hansen, J.M.; Kristensen, M. and Skovsted, L.: Sulthiame (Ospolot®) as inhibitor of diphenylhydantoin metabolism. Epilepsia 9: 17–22 (1968).

    PubMed  CAS  Google Scholar 

  • Hansen, J.M.; Siersbaek-Nielsen, K.; Kristensen, M.; Skovsted, L. and Christensen, L.K.: Effect of diphenylhydantoin on the metabolism of dicoumarol in man. Acta Medica Scandinavica 189: 15–19 (1971).

    PubMed  CAS  Google Scholar 

  • Hansen, J.M.; Kampmann, J.P.; Siersbaek-Nielsen, K.; Lumholtz, I.B.; Arroe, M.; Abildgaard, V. and Skovsted, L: The effect of different sulphonamides on phenytoin metabolism in man. Acta Medica Scandinavica 624 (Suppl.): 106–110 (1979).

    PubMed  CAS  Google Scholar 

  • Haque, N.; Thrasher, K.; Werk, E.E. Jr; Knowles, H.C. Jr and Sholiton, L.J.: Studies on dexamethasone metabolism in man: Effect of diphenylhydantoin. Journal of Clinical Endocrinology and Metabolism 34: 44–50 (1972).

    PubMed  CAS  Google Scholar 

  • Hempel, E. and Klinger, W.: Drug stimulated biotransformation of hormonal steroid contraceptives: Clinical implications. Drugs 12: 442–448 (1976).

    PubMed  CAS  Google Scholar 

  • Herishanu, Y.; Eylath, V. and Ilan, R.: Effect of calcium content of diet on absorption of diphenylhydantoin. Israel Journal of Medical Sciences 12: 1453–1456 (1976).

    PubMed  CAS  Google Scholar 

  • Houghton, G.W. and Richens, A.: Inhibition of phenytoin metabolism by sulthiame in epileptic patients. British Journal of Clinical Pharmacology 1: 59–66 (1974).

    PubMed  CAS  Google Scholar 

  • Jubiz, W.; Meikle, A.W.; Levinson, R.A.; Mizutani, S.; West C.D. and Tyler, F.H.: Effect of diphenylhydantoin on the metabolism of dexamethasone. New England Journal of Medicine 283: 11–14 (1970).

    PubMed  CAS  Google Scholar 

  • Karch, F.E.; Wardell, W.M.; Dambly, M. and Gringeri, A.: Effect of halofenate on the serum binding of phenytoin. British Journal of Clinical Pharmacology 4: 625–626 (1977).

    PubMed  CAS  Google Scholar 

  • Karlsson, E.; Collste, P. and Rawlins, M.D.: Plasma levels of lidocaine during combined treatment with phenytoin and procainamide. European Journal of Clinical Pharmacology 7: 455–459 (1974).

    PubMed  CAS  Google Scholar 

  • Kater, R.M.H.; Roggin, G.; Tobon, F.; Zieve, P. and Iber, F.L.: Increased rate of clearance of drugs from the circulation of alcoholics. American Journal of the Medical Sciences 258: 35–39 (1969).

    PubMed  CAS  Google Scholar 

  • Koch-Weser, J.: Hemorrhagic reactions and drug interactions in 500 warfarin-treated patients. Clinical Pharmacology and Therapeutics 14: 139 (1973).

    Google Scholar 

  • Koranyi, L. and Gero, L.: Influence of diphenylhydantoin on the effect of streptozotocin. British Medical Journal 1: 127 (1979).

    PubMed  CAS  Google Scholar 

  • Koup, J.R.; Gibaldi, M.; McNamara, P.; Hilligoss, D.M.; Colburn, W.A. and Bruck, E.: Interaction of chloramphenicol with phenytoin and phenobarbital. Clinical Pharmacology and Therapeutics 24: 571–575 (1978).

    PubMed  CAS  Google Scholar 

  • Kulshrestha, V.K.; Thomas, M.; Wadsworth, J. and Richens, A.: Interaction between phenytoin and antacids. British Journal of Clinical Pharmacology 6: 177–179 (1978).

    PubMed  CAS  Google Scholar 

  • Kurata, D. and Wilkinson, G.R.: Erythrocyte uptake and plasma binding of diphenylhydantoin. Clinical Pharmacology and Therapeutics 16: 355–362 (1974).

    PubMed  CAS  Google Scholar 

  • Kutt, H.: Biochemical and genetical factors regulating Dilantin® metabolism in man. Annals of the New York Academy of Sciences 179: 704–722 (1971).

    CAS  Google Scholar 

  • Kutt, H.: Diphenylhydantoin. Interactions with other drugs in man; in Woodbury et al. (Eds) Antiepileptic Drugs pp. 169–180 (Raven Press, New York 1972).

    Google Scholar 

  • Kutt, H.: Interactions of antiepileptic drugs. Epilepsia 16: 393–401 (1975).

    PubMed  CAS  Google Scholar 

  • Kutt, H.; Winters, W. and McDowell, F.H.: Depression of parahydroxylation of diphenylhydantoin by antituberculosis chemotherapy. Neurology 16: 594–602 (1966).

    PubMed  CAS  Google Scholar 

  • Kutt, H.; Brennan, R.; Dehejia, H. and Verebely, K.: Diphenylhydantoin intoxication. A complication of isoniazid therapy. American Review of Respiratory Diseases 101: 377–384 (1970).

    CAS  Google Scholar 

  • Lunde, P.K.M.; Rane, A.; Yaffe, S.J.; Lund, L. and Sjoqvist, F.: Plasma protein binding of diphenylhydantoin in man. Clinical Pharmacology and Therapeutics 11: 846–855 (1970).

    PubMed  CAS  Google Scholar 

  • MacCallum, W.A.G.: Interaction of lithium and phenytoin. British Medical Journal 280: 610–611 (1980).

    PubMed  CAS  Google Scholar 

  • Makki, K.A.; Perucca, E. and Richens, A.: Metabolic effects of folic acid replacement therapy in folate-deficient epileptic patients; in Johannesson et al. (Eds) Antiepileptic Therapy: Advances in Drug Monitoring, pp.391–396 (Raven Press, New York 1980).

    Google Scholar 

  • Mattson, R.H.; Gallagher, B.B.; Reynolds, E.H. and Glass, D.: Folate therapy in epilepsy. A controlled study. Archives of Neurology 29: 78–81 (1973).

    PubMed  CAS  Google Scholar 

  • Mattson, R.H.; Cramer, J.A.; Williamson, P.C. and Novelly, R.A.: Valproic acid in epilepsy: Clinical and pharmacological effects. Annals of Neurology 3: 20–25 (1978).

    PubMed  CAS  Google Scholar 

  • McLelland, J. and Jack, W.: Phenytoin/dexamethasone interaction: A clinical problem. Lancet 1: 1096–1097 (1978).

    PubMed  CAS  Google Scholar 

  • Meikle, A.W.; Jubiz, W.; Matsukura, S.; West, C.D. and Tyler, F.H.: Effect of diphenylhydantoin on the metabolism of metyrapone and release of ACTH in man. Journal of Clinical Endocrinology and Metabolism 29: 1553–1558 (1969).

    PubMed  CAS  Google Scholar 

  • Miller, R.R.; Porter, J. and Greenblatt, D.J.: Clinical importance of the interaction of phenytoin and isoniazid. A report from the Boston Collaborative Drug Surveillance Program. Chest 75: 356–358 (1979).

    PubMed  CAS  Google Scholar 

  • Monks, A. and Richens, A.: Effect of a single dose of sodium valproate on serum phenytoin concentration and protein binding in epileptic patients. Clinical Pharmacology and Therapeutics. In press (1980).

    Google Scholar 

  • Monks, A.; Boobis, S.; Wadsworth, J. and Richens, A.: Plasma protein binding interaction between phenytoin and valproic acid in vitro. British Journal of Clinical Pharmacology 6: 487–492 (1978).

    PubMed  CAS  Google Scholar 

  • Morselli, P.; Rizzo, M. and Garattini, S.: Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients. Annals of the New York Academy of Sciences 179: 88–107 (1971).

    PubMed  CAS  Google Scholar 

  • Murray, F.J.: Outbreak of unexpected reactions among epileptics taking isoniazid. American Review of Respiratory Diseases 86: 729–732 (1962).

    CAS  Google Scholar 

  • Nappi, J.: Warfarin and phenytoin interaction. Annals of Internal Medicine 90: P52 (1979).

    Google Scholar 

  • Neuvonen, P.J.; Elfving, S.M. and Elonen, E.: Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man. European Journal of Clinical Pharmacology 13: 213–218 (1978).

    PubMed  CAS  Google Scholar 

  • Neuvonen, P.J.; Lehtovaara, R.; Bardy, A. and Elonen, E.: Antipyrine analgesics in patients on antiepileptic drug therapy. European Journal of Clinical Pharmacology 15: 263–268 (1979).

    PubMed  CAS  Google Scholar 

  • O’Brien, L.S.; Orme, M.I’E. and Breckenridge, A.M.: Failure of antacids to alter the pharmacokinetics of phenytoin. British Journal of Clinical Pharmacology 6: 176–177 (1978).

    PubMed  Google Scholar 

  • Odar-Cederlof, I. and Borgå, O.: Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid. Clinical Pharmacology and Therapeutics 20: 36–47 (1976).

    PubMed  CAS  Google Scholar 

  • Olesen, O.V.: The influence of disulferain and calcium carbide on the serum diphenylhydantoin. Excretion of HPPH in the urine. Archives of Neurology 16: 642–644 (1967).

    PubMed  CAS  Google Scholar 

  • Padgham, C. and Richens, A.: Quinine metabolism: A useful index of hepatic enzyme-induction in man? British Journal of Clinical Pharmacology 1: 352–353 (1974).

    CAS  Google Scholar 

  • Patsalos, P.N. and Lascelles, P.T.: Effect of sodium valproate on plasma protein binding of diphenylhydantoin. Journal of Neurology, Neurosurgery and Psychiatry 40: 570–574 (1977).

    CAS  Google Scholar 

  • Paxton, J.W.: Effects of aspirin on salivary and serum phenytoin kinetics in healthy subjects. Clinical Pharmacology and Therapeutics 27: 170–178 (1980).

    PubMed  CAS  Google Scholar 

  • Penry, J.K. and Newmark, M.E.: The use of antiepileptic drugs. Annals of Internal Medicine 90: 207–218 (1979).

    PubMed  CAS  Google Scholar 

  • Penttila, O.; Neuvonen, P.J.; Aho, K. and Lehtovaara, R.: Interaction between doxycycline and some antiepileptic drugs. British Medical Journal 2: 470–472 (1974).

    PubMed  CAS  Google Scholar 

  • Perucca, E.: Clinical consequences of microsomal enzyme-induction by antiepileptic drugs. Pharmacology and Therapeutics 2: 285–314 (1978).

    CAS  Google Scholar 

  • Perucca, E. and Richens, A.: Interaction between phenytoin and imipramine. British Journal of Clinical Pharmacology 4: 484–486 (1977).

    Google Scholar 

  • Perucca, E. and Richens, A.: Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs. British Journal of Clinical Pharmacology 7: 201–206 (1979a).

    PubMed  CAS  Google Scholar 

  • Perucca, E. and Richens, A.: Reduction of the oral availability of lignocaine by induction of first-pass metabolism in epileptic patients. British Journal of Clinical Pharmacology 8: 21–31 (1979b).

    PubMed  CAS  Google Scholar 

  • Perucca, E. and Richens, A.: Water intoxication produced by carbamazepine, and its reversal by phenytoin. Journal of Neurology, Neurosurgery and Psychiatry 43: 540–545 (1980a).

    CAS  Google Scholar 

  • Perucca, E. and Richens, A.: Interpretation of drug levels: Relevance of plasma protein binding; in Drug Concentrations in Neuropsychiatry, Ciba Foundation Symposium 74, pp.51–68 (Excerpta Medica, Amsterdam 1980b).

    Google Scholar 

  • Perucca, E. and Richens, A.: Antiepileptic drug interactions; in Tyrer (Ed) Current Topics in Therapeutics, in press (MTD Press, Lancaster 1980c).

    Google Scholar 

  • Perucca, E. and Richens, A.: Interaction between carbamazepine and lithium. British Medical Journal 280: 863 (1980d).

    PubMed  CAS  Google Scholar 

  • Perucca, E.; Gatti, G.; Frigo, G.M.; Crema, A.; Calzetti, S. and Visintini, D.: Disposition of sodium valproate in epileptic patients. British Journal of Clinical Pharmacology 5: 495–499 (1978).

    PubMed  CAS  Google Scholar 

  • Perucca, E., Hedges, A-M.; Makki, K.; Hebdige, S.; Wadsworth, J. and Richens, A.: The comparative enzyme-inducing properties of antiepileptic drugs. British Journal of Clinical Pharmacology 7: 414–415 (1979).

    Google Scholar 

  • Perucca, E.; Hebdige, S.; Gatti, G.; Lecchini, S.; Frigo, G.M. and Crema, A.: Interaction between phenytoin and valproic acid: Plasma protein binding and metabolic effects. Clinical Pharmacology and Therapeutics. In press (1980).

    Google Scholar 

  • Petereit, L.B. and Meikle, A.W.: Effectiveness of prednisolone during phenytoin therapy. Clinical Pharmacology and Thera peutics 22: 912–916 (1977).

    CAS  Google Scholar 

  • Petruch, F.; Schüffei, R.V.A. and Steinhilber, G.: Effect of diphenylhydantoin on hepatic drug hydroxylation. European Journal of Clinical Pharmacology 7: 281–285 (1974).

    PubMed  CAS  Google Scholar 

  • Porter, R.J. and Layzer, R.P.: Plasma albumin concentration and diphenylhydantoin binding in man. Archives of Neurology 32: 298–303(1975).

    PubMed  CAS  Google Scholar 

  • Pugh, R.N.H.; Geddes, A.M. and Yeoman, W.B.. Interaction of phenytoin and chlorpheniramine. British Journal of Clinical Pharmacology 2: 173–174(1975).

    PubMed  CAS  Google Scholar 

  • Rambeck, B.: P armacological interactions of mesuximide with phénobarbital and phenytoin in hospitalized epileptic patients. Epilepsia 20: 147–156 (1979).

    PubMed  CAS  Google Scholar 

  • Reynolds, E.H,: Neurological aspects of folate and B12 metabolism. Clinics in Haematology 5: 661–696 (1976).

    PubMed  CAS  Google Scholar 

  • Richens, A. and Houghton, G.W.: Effect of drug therapy on the metabolism of phenytoin; in Schneider et al. (Eds) Clinical Pharmacology of Anti-Epileptic Drugs, pp.87–95 (Springer-Verlag, Berlin 1975).

    Google Scholar 

  • Richter, E.; Breimer, D.D. and Zilly, W.: Disposition of hexobarbital in intra- and extrahepatic cholestasis in man and the influence of drug metabolism-inducing agents. European Journal of Clinical Pharmacology 17: 197–202(1980).

    PubMed  CAS  Google Scholar 

  • Riddell, J.G.; Salem, S.A.M. and McDevitt, D.G.: Interaction between phenytoin and dichloralphenazone. British Journal of Clinical Pharmacology 9: 118 (1980).

    Google Scholar 

  • Roe, T.F.; Podosin, R.L. and Blaskovics, M.E.: Drug interaction: Diazoxide and diphenylhydantoin. Journal of Pediatrics 9: 285 (1975).

    Google Scholar 

  • Rose, J.Q.; Choi, H.K.; Schentag, J.J.; Kinkel, W.R. and Jusko, W.J.: Intoxication caused by interaction of chloramphenicol and phenytoin. Journal of the American Medical Association 237: 2630–2631 (1977).

    PubMed  CAS  Google Scholar 

  • Sackellares, J.C.; Lee, S.I. and Dreifuss, F.E.: Stupor following administration of valproic acid to patients receiving other antiepileptic drugs. Epilepsia 20: 697–703 (1979).

    PubMed  CAS  Google Scholar 

  • Sandor, P.; Sellers, E.M.; Khouw, V. and Fan, T.: Phenytoin disposition during alcohol ingestion and withdrawal. Clinical Pharmacology and Therapeutics 27: 283 (1980).

    Google Scholar 

  • Skovsted, L.; Kristensen, M.; Hansen, J.M. and Siersbaek-Nielsen, K.: The effect of different oral anticoagulants on diphenylhydantoin and tolbutamide metabolism. Acta Medica Scandinavica 199: 513–515(1976).

    PubMed  CAS  Google Scholar 

  • Solomon, H.M. and Schrogie, J.J.: The effect of phenyramidol on the metabolism of diphenylhydantoin. Clinical Pharmacology and Therapeutics 8: 554–556 (1967).

    PubMed  CAS  Google Scholar 

  • Solomon, H.M.; Reich, S.; Spirt, N. and Abrams, W.B.: Interaction between digitoxin and other drugs in vitro and in vivo. Annals of the New York Academy of Sciences 179: 362–369 (1971).

    PubMed  CAS  Google Scholar 

  • Sotaniemi, E.A.; Pelkonen, R.O.; Ahokas, J.; Pirttiaho, H.I. and Ahlqvist, J.: Drug metabolism in epileptics: in vivo and in vitro correlations. British Journal of Clinical Pharmacology 5: 71–76 (1978).

    PubMed  CAS  Google Scholar 

  • Stjernholm, M.R. and Katz, F.H.: Effects of diphenylhydantoin, phenobarbital and diazepam on metabolism of methylprednisolone and its sodium succinate. Journal of Clinical Endocrinology and Metabolism 41: 887–893 (1975).

    PubMed  CAS  Google Scholar 

  • Viala, A.; Cano, J.P.; Dravet, L.; Tassinari, C.A.; Roger, J. and Angeletti-Philippe, A.: Blood levels of diazepam (Valium) and N-desmethyl-diazepam in the epileptic child. A preliminary report. Psychiatria Neurologia et Neurochirurgia 74: 153–158 (1971).

    CAS  Google Scholar 

  • Vincent, F.M.: Phenothiazine-induced phenytoin intoxication. Annals of Internal Medicine 93: 56–57 (1980).

    PubMed  CAS  Google Scholar 

  • Wasserman, T.H.; Phillips, T.L.; Vauraalte, G.; Urtasun, R.; Partington, J.; Kozid, D.; Schwade, J.G.; Gangji, D. and Strong, J.M.: Neurotoxicity of misonidazole. Potential modifying role of phenytoin sodium and dexamethasone. British Journal of Radiology 53: 172–173 (1980).

    PubMed  CAS  Google Scholar 

  • Werk, E.E.; McGee, J. and Sholiton, L.J.: Effect of diphenylhydantoin on cortisol metabolism in man. Journal of Clinical Investigation 43: 1824–1835 (1964).

    PubMed  CAS  Google Scholar 

  • Wesseling, H. and Mols-Thürkow, I.: Interaction of diphenylhydantoin (DPH) and tolbutamide in man. European Journal of Clinical Pharmacology 8: 75–78 (1975).

    PubMed  CAS  Google Scholar 

  • Workman, P.; Bleehen, N.M. and Wiltshire, C.R.: Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: Implications for possible reduced toxicity. British Journal of Cancer 41: 302–304 (1980).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Pharmacology Unit, Institute of Neurology, National Hospital, Queen Square, London, WC1 3BG, England

    Emilio Perucca &  Alan Richens

Authors
  1. Emilio Perucca
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alan Richens
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perucca, E., Richens, A. Drug Interactions with Phenytoin. Drugs 21, 120–137 (1981). https://doi.org/10.2165/00003495-198121020-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198121020-00003

Keywords

Search

Navigation